Key result
Various vaccine platforms, including inactivated viruses, live attenuated strains, and virus-like particles, are under development to prevent severe non-polio enterovirus infections in children.
Why the study?
Non-polio enteroviruses cause severe complications such as myocarditis and meningitis in children, and vaccination represents the most promising preventive strategy.
This review outlines the epidemiology of non-polio enteroviruses and highlights virus-like particles as a promising platform for developing safe, polyvalent vaccines to prevent severe complications like myocarditis and meningitis.
Vaccine development for non-polio enteroviruses remains early-stage; leaves open which platforms will prove safe and effective in children.
Non-polio enteroviruses (NPEVs) are ubiquitous and are one of the main causative agents of viral infections in children. NPEVs most commonly infect newborns and young children, due to their lack of antibodies. In children, clinical manifestations can range from acute febrile illness to severe complications that require hospitalization and lead in some cases to disability or death. NPEV infections can have severe consequences, such as polio-like diseases, serous meningitis, meningoencephalitis, myocarditis, etc. The most promising strategy for preventing such diseases is vaccination. No less than 53 types of NPEVs have been found to circulate in Russia. However, of epidemic importance are the causative agents of exanthemic forms of the disease, aseptic meningitis and myocarditis. At the same time, the frequency of NPEV detection in the constituent entities of the Russian Federation is characterized by uneven distribution and seasonal upsurges. The review discusses the epidemic significance of different types of enteroviruses, including those relevant to the Russian Federation, as well as current technologies used to create enterovirus vaccines for the prevention of serious diseases.
No takes yet. Share an insight, caveat, or question.
Новиков et al. (2022) conducted a review in Non-polio enterovirus infections. Non-polio enterovirus vaccines was evaluated. Various vaccine platforms, including inactivated viruses, live attenuated strains, and virus-like particles, are under development to prevent severe non-polio enterovirus infections in children.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: